Reuters: Health
Acasti Pharma Inc said on Monday its krill oil-derived drug candidate, CaPre, was not more effective than placebo in reducing high levels of triglycerides in a late-stage study.
Acasti Pharma's krill oil-derived drug fails late-stage study
Acasti Pharma's krill oil-derived drug fails late-stage study
Reuters: Health
Acasti Pharma Inc said on Monday its krill oil-derived drug candidate, CaPre, was not more effective than placebo in reducing high levels of triglycerides in a late-stage study.
Reuters: Health
Acasti Pharma Inc said on Monday its krill oil-derived drug candidate, CaPre, was not more effective than placebo in reducing high levels of triglycerides in a late-stage study.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment